SCHEMBL5041808

SCHEMBL5041808

COc1ccc(COCC(=O)O)cc1OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 2/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
RXRA P19793 1/20 0.55
MRGPRX4 Q96LA9 2/20 0.54
ATM Q13315 1/20 0.53
ABCB1 P08183 1/20 0.53
ABCG2 Q9UNQ0 1/20 0.53
FFAR1 O14842 1/20 0.53
FFAR4 Q5NUL3 1/20 0.53
BCHE P06276 1/20 0.53
ALDH1A1 P00352 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 1/20 0.52
HPGD P15428 1/20 0.52
RAB9A P51151 1/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
MTNR1A P48039 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320348 0.87 LDHA (0.57) ALDH1A1SMN1; SMN2NPC1HPGDPOLB
SCHEMBL2391945 0.85 SMPD1 (0.61) SMPD1HDAC1HDAC8HDAC6RXRA
SCHEMBL7822529 0.82 FFAR4 (0.73) SMPD1HDAC1HDAC8HDAC6FFAR1
SCHEMBL10730593 0.81 SMPD1 (0.60) SMPD1HDAC1HDAC8HDAC6RXRA
SCHEMBL8844454 0.80 SLC6A2 (0.60) SMPD1HDAC1HDAC8HDAC6RXRA
SCHEMBL31361425 0.80 BCHE (0.60) SMPD1HDAC1HDAC8HDAC6RXRA
SCHEMBL3239903 0.80 BCHE (0.60) SMPD1HDAC1HDAC8HDAC6RXRA
SCHEMBL2394315 0.80 SMPD1 (0.59) SMPD1HDAC1HDAC8HDAC6RXRA
SCHEMBL1114985 0.79 NPC1 (0.63) RXRAATMALDH1A1SMN1; SMN2NPC1
SCHEMBL31011346 0.79 NPC1 (0.63) RXRAATMALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 SMPD1 369/4885HDAC1 3142/4885HDAC8 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.